APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medical Sevofluran

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Medical Sevofluran Industry Growth and Trends Forecast to 2032

26 December 2025107 pages

Choose your research edition.

Industry ResearchMedical Sevofluran Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Sevofluran Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Medical Sevofluran Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Sevofluran Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Sevofluran Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Medical Sevofluran market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Medical Sevofluran is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Medical Sevofluran is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Sevofluran is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medical Sevofluran include Abbott Laboratories, Hengrui, Baxter, Abbvie, Shenzhen Mindray Bio-Medical Electronics, Scott Medical Products, Piramal, Mylan Seiyaku and Maruishi Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Medical Sevofluran market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Medical Sevofluran market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Medical Sevofluran market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Medical Sevofluran.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Medical Sevofluran market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Medical Sevofluran Market by Company

Abbott Laboratories

Hengrui

Baxter

Abbvie

Shenzhen Mindray Bio-Medical Electronics

Scott Medical Products

Piramal

Mylan Seiyaku

Maruishi Pharmaceutical

Lunan

Jinan MingRui

Hikma

Collins Ltd

BOC Healthcare

Medical Sevofluran Segment by Type

Generic Drug

Original Drug

Medical Sevofluran Segment by Application

Children

Adults

Medical Sevofluran Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Sevofluran market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Sevofluran and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Sevofluran.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Medical Sevofluran manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Medical Sevofluran in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Generic Drug Table 2. Major Company of Original Drug Table 3. Global Medical Sevofluran Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Medical Sevofluran Sales by Type (2021-2026) & (Tons) Table 5. Global Medical Sevofluran Sales Market Share in Volume by Type (2021-2026) Table 6. Global Medical Sevofluran Sales by Type (2021-2026) & (US$ Million) Table 7. Global Medical Sevofluran Sales Market Share in Value by Type (2021-2026) Table 8. Global Medical Sevofluran Price by Type (2021-2026) & (US$/Ton) Table 9. Global Medical Sevofluran Sales by Type (2027-2032) & (Tons) Table 10. Global Medical Sevofluran Sales Market Share in Volume by Type (2027-2032) Table 11. Global Medical Sevofluran Sales by Type (2027-2032) & (US$ Million) Table 12. Global Medical Sevofluran Sales Market Share in Value by Type (2027-2032) Table 13. Global Medical Sevofluran Price by Type (2027-2032) & (US$/Ton) Table 14. North America Medical Sevofluran Sales by Type (2021-2026) & (Tons) Table 15. North America Medical Sevofluran Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Medical Sevofluran Sales by Type (2021-2026) & (Tons) Table 17. Europe Medical Sevofluran Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Medical Sevofluran Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Medical Sevofluran Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Medical Sevofluran Sales by Type (2021-2026) & (Tons) Table 21. Latin America Medical Sevofluran Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Medical Sevofluran Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Medical Sevofluran Sales by Type (2021-2026) & (US$ Million) Table 24. Medical Sevofluran Industry Trends Table 25. Medical Sevofluran Industry Drivers Table 26. Medical Sevofluran Industry Opportunities and Challenges Table 27. Medical Sevofluran Industry Restraints Table 28. Global Medical Sevofluran Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Medical Sevofluran Revenue Market Share by Company (2021-2026) Table 30. Global Medical Sevofluran Sales by Company (2021-2026) & (Tons) Table 31. Global Medical Sevofluran Sales Share by Company (2021-2026) Table 32. Global Medical Sevofluran Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Medical Sevofluran Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Medical Sevofluran Major Company Production Sites and Headquarters Table 35. Global Medical Sevofluran Company, Product Type & Application Table 36. Global Medical Sevofluran Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Medical Sevofluran by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Medical Sevofluran Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Medical Sevofluran Sales by Region (2021-2026) & (Tons) Table 41. Global Medical Sevofluran Sales Market Share in Volume by Region (2021-2026) Table 42. Global Medical Sevofluran Sales by Region (2021-2026) & (US$ Million) Table 43. Global Medical Sevofluran Sales Market Share in Value by Region (2021-2026) Table 44. Global Medical Sevofluran Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Medical Sevofluran Sales by Region (2027-2032) & (Tons) Table 46. Global Medical Sevofluran Sales Market Share in Volume by Region (2027-2032) Table 47. Global Medical Sevofluran Sales by Region (2027-2032) & (US$ Million) Table 48. Global Medical Sevofluran Sales Market Share in Value by Region (2027-2032) Table 49. Global Medical Sevofluran Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Medical Sevofluran Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Medical Sevofluran Sales by Application (2021-2026) & (Tons) Table 52. Global Medical Sevofluran Sales Market Share in Volume by Application (2021-2026) Table 53. Global Medical Sevofluran Sales by Application (2021-2026) & (US$ Million) Table 54. Global Medical Sevofluran Sales Market Share in Value by Application (2021-2026) Table 55. Global Medical Sevofluran Price by Application (2021-2026) & (US$/Ton) Table 56. Global Medical Sevofluran Sales by Application (2027-2032) & (Tons) Table 57. Global Medical Sevofluran Sales Market Share in Volume by Application (2027-2032) Table 58. Global Medical Sevofluran Sales by Application (2027-2032) & (US$ Million) Table 59. Global Medical Sevofluran Sales Market Share in Value by Application (2027-2032) Table 60. Global Medical Sevofluran Price by Application (2027-2032) & (US$/Ton) Table 61. North America Medical Sevofluran Sales by Application (2021-2026) & (Tons) Table 62. North America Medical Sevofluran Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Medical Sevofluran Sales by Application (2021-2026) & (Tons) Table 64. Europe Medical Sevofluran Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Medical Sevofluran Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Medical Sevofluran Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Medical Sevofluran Sales by Application (2021-2026) & (Tons) Table 68. Latin America Medical Sevofluran Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Medical Sevofluran Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Medical Sevofluran Sales by Application (2021-2026) & (US$ Million) Table 71. Abbott Laboratories Company Information Table 72. Abbott Laboratories Business Overview Table 73. Abbott Laboratories Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Abbott Laboratories Medical Sevofluran Product Portfolio Table 75. Abbott Laboratories Recent Development Table 76. Hengrui Company Information Table 77. Hengrui Business Overview Table 78. Hengrui Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Hengrui Medical Sevofluran Product Portfolio Table 80. Hengrui Recent Development Table 81. Baxter Company Information Table 82. Baxter Business Overview Table 83. Baxter Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. Baxter Medical Sevofluran Product Portfolio Table 85. Baxter Recent Development Table 86. Abbvie Company Information Table 87. Abbvie Business Overview Table 88. Abbvie Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Abbvie Medical Sevofluran Product Portfolio Table 90. Abbvie Recent Development Table 91. Shenzhen Mindray Bio-Medical Electronics Company Information Table 92. Shenzhen Mindray Bio-Medical Electronics Business Overview Table 93. Shenzhen Mindray Bio-Medical Electronics Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Shenzhen Mindray Bio-Medical Electronics Medical Sevofluran Product Portfolio Table 95. Shenzhen Mindray Bio-Medical Electronics Recent Development Table 96. Scott Medical Products Company Information Table 97. Scott Medical Products Business Overview Table 98. Scott Medical Products Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Scott Medical Products Medical Sevofluran Product Portfolio Table 100. Scott Medical Products Recent Development Table 101. Piramal Company Information Table 102. Piramal Business Overview Table 103. Piramal Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. Piramal Medical Sevofluran Product Portfolio Table 105. Piramal Recent Development Table 106. Mylan Seiyaku Company Information Table 107. Mylan Seiyaku Business Overview Table 108. Mylan Seiyaku Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Mylan Seiyaku Medical Sevofluran Product Portfolio Table 110. Mylan Seiyaku Recent Development Table 111. Maruishi Pharmaceutical Company Information Table 112. Maruishi Pharmaceutical Business Overview Table 113. Maruishi Pharmaceutical Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 114. Maruishi Pharmaceutical Medical Sevofluran Product Portfolio Table 115. Maruishi Pharmaceutical Recent Development Table 116. Lunan Company Information Table 117. Lunan Business Overview Table 118. Lunan Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 119. Lunan Medical Sevofluran Product Portfolio Table 120. Lunan Recent Development Table 121. Jinan MingRui Company Information Table 122. Jinan MingRui Business Overview Table 123. Jinan MingRui Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 124. Jinan MingRui Medical Sevofluran Product Portfolio Table 125. Jinan MingRui Recent Development Table 126. Hikma Company Information Table 127. Hikma Business Overview Table 128. Hikma Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 129. Hikma Medical Sevofluran Product Portfolio Table 130. Hikma Recent Development Table 131. Collins Ltd Company Information Table 132. Collins Ltd Business Overview Table 133. Collins Ltd Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 134. Collins Ltd Medical Sevofluran Product Portfolio Table 135. Collins Ltd Recent Development Table 136. BOC Healthcare Company Information Table 137. BOC Healthcare Business Overview Table 138. BOC Healthcare Medical Sevofluran Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 139. BOC Healthcare Medical Sevofluran Product Portfolio Table 140. BOC Healthcare Recent Development Table 141. North America Medical Sevofluran Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. North America Medical Sevofluran Sales by Country (2021-2026) & (Tons) Table 143. North America Medical Sevofluran Sales Market Share by Country (2021-2026) Table 144. North America Medical Sevofluran Sales Forecast by Country (2027-2032) & (Tons) Table 145. North America Medical Sevofluran Sales Market Share Forecast by Country (2027-2032) Table 146. North America Medical Sevofluran Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Medical Sevofluran Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Medical Sevofluran Market Share by Country (2021-2026) Table 149. North America Medical Sevofluran Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Medical Sevofluran Market Share Forecast by Country (2027-2032) Table 151. Europe Medical Sevofluran Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Europe Medical Sevofluran Sales by Country (2021-2026) & (Tons) Table 153. Europe Medical Sevofluran Sales Market Share by Country (2021-2026) Table 154. Europe Medical Sevofluran Sales Forecast by Country (2027-2032) & (Tons) Table 155. Europe Medical Sevofluran Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Medical Sevofluran Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Medical Sevofluran Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Medical Sevofluran Market Share by Country (2021-2026) Table 159. Europe Medical Sevofluran Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Medical Sevofluran Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Medical Sevofluran Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Medical Sevofluran Sales by Country (2021-2026) & (Tons) Table 163. Asia-Pacific Medical Sevofluran Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Medical Sevofluran Sales Forecast by Country (2027-2032) & (Tons) Table 165. Asia-Pacific Medical Sevofluran Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Medical Sevofluran Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Medical Sevofluran Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Medical Sevofluran Market Share by Country (2021-2026) Table 169. Asia-Pacific Medical Sevofluran Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Medical Sevofluran Market Share Forecast by Country (2027-2032) Table 171. Latin America Medical Sevofluran Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 172. Latin America Medical Sevofluran Sales by Country (2021-2026) & (Tons) Table 173. Latin America Medical Sevofluran Sales Market Share by Country (2021-2026) Table 174. Latin America Medical Sevofluran Sales Forecast by Country (2027-2032) & (Tons) Table 175. Latin America Medical Sevofluran Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Medical Sevofluran Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Medical Sevofluran Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Medical Sevofluran Market Share by Country (2021-2026) Table 179. Latin America Medical Sevofluran Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Medical Sevofluran Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Medical Sevofluran Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Medical Sevofluran Sales by Country (2021-2026) & (Tons) Table 183. Middle East and Africa Medical Sevofluran Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Medical Sevofluran Sales Forecast by Country (2027-2032) & (Tons) Table 185. Middle East and Africa Medical Sevofluran Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Medical Sevofluran Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Medical Sevofluran Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Medical Sevofluran Market Share by Country (2021-2026) Table 189. Middle East and Africa Medical Sevofluran Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Medical Sevofluran Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Medical Sevofluran Distributors List Table 194. Medical Sevofluran Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Medical Sevofluran Image Figure 2. Global Medical Sevofluran Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Sevofluran Market Size (2021-2032) & (US$ Million) Figure 4. Global Medical Sevofluran Sales (2021-2032) & (Tons) Figure 5. Generic Drug Image Figure 6. Global Generic Drug Sales YoY Growth (2021-2032) & (Tons) Figure 7. Original Drug Image Figure 8. Global Original Drug Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Medical Sevofluran Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Medical Sevofluran Market Share by Type 2025 VS 2032 Figure 11. North America Medical Sevofluran Sales Market Share in Volume by Type in 2025 Figure 12. North America Medical Sevofluran Sales Market Share in Value by Type in 2025 Figure 13. Europe Medical Sevofluran Sales Market Share in Volume by Type in 2025 Figure 14. Europe Medical Sevofluran Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Medical Sevofluran Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Medical Sevofluran Sales Market Share in Value by Type in 2025 Figure 17. Latin America Medical Sevofluran Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Medical Sevofluran Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Medical Sevofluran Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Medical Sevofluran Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Medical Sevofluran Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (Tons) Figure 25. Adults Image Figure 26. Global Adults Sales YoY Growth (2021-2032) & (Tons) Figure 27. Global Medical Sevofluran Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Medical Sevofluran Market Share by Application 2025 VS 2032 Figure 29. North America Medical Sevofluran Sales Market Share in Volume by Application in 2025 Figure 30. North America Medical Sevofluran Sales Market Share in Value by Application in 2025 Figure 31. Europe Medical Sevofluran Sales Market Share in Volume by Application in 2025 Figure 32. Europe Medical Sevofluran Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Medical Sevofluran Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Medical Sevofluran Sales Market Share in Value by Application in 2025 Figure 35. Latin America Medical Sevofluran Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Medical Sevofluran Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Medical Sevofluran Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Medical Sevofluran Sales Market Share in Value by Application in 2025 Figure 39. North America Medical Sevofluran Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 40. North America Medical Sevofluran Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Medical Sevofluran Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Medical Sevofluran Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. Europe Medical Sevofluran Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Medical Sevofluran Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Medical Sevofluran Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Asia-Pacific Medical Sevofluran Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Medical Sevofluran Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Medical Sevofluran Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Latin America Medical Sevofluran Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Medical Sevofluran Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Medical Sevofluran Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Middle East and Africa Medical Sevofluran Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Medical Sevofluran Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Medical Sevofluran Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Medical Sevofluran Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Medical Sevofluran Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Children
  • Adults
Companies covered
  • Abbott Laboratories
  • Hengrui
  • Baxter
  • Abbvie
  • Shenzhen Mindray Bio-Medical Electronics
  • Scott Medical Products
  • Piramal
  • Mylan Seiyaku
  • Maruishi Pharmaceutical
  • Lunan
  • Jinan MingRui
  • Hikma
  • Collins Ltd
  • BOC Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Sevofluran Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medical Sevofluran Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Medical Sevofluran Market by Type
  6. 1.3.1 Generic Drug
  7. 1.3.2 Original Drug
  8. 1.4 Global Medical Sevofluran Market Size by Type
  9. 1.4.1 Global Medical Sevofluran Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Medical Sevofluran Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Medical Sevofluran Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Medical Sevofluran Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Medical Sevofluran Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Medical Sevofluran Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Medical Sevofluran Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Medical Sevofluran Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Medical Sevofluran Industry Trends
  2. 2.2 Medical Sevofluran Industry Drivers
  3. 2.3 Medical Sevofluran Industry Opportunities and Challenges
  4. 2.4 Medical Sevofluran Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Medical Sevofluran Revenue (2021-2026)
  2. 3.2 Global Top Players by Medical Sevofluran Sales (2021-2026)
  3. 3.3 Global Top Players by Medical Sevofluran Price (2021-2026)
  4. 3.4 Global Medical Sevofluran Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medical Sevofluran Major Company Production Sites & Headquarters
  6. 3.6 Global Medical Sevofluran Company, Product Type & Application
  7. 3.7 Global Medical Sevofluran Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medical Sevofluran Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medical Sevofluran Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Medical Sevofluran Tier 1, Tier 2, and Tier 3
4 Medical Sevofluran Regional Status and Outlook
  1. 4.1 Global Medical Sevofluran Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Medical Sevofluran Historic Market Size by Region
  3. 4.2.1 Global Medical Sevofluran Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Medical Sevofluran Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Medical Sevofluran Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Medical Sevofluran Forecasted Market Size by Region
  7. 4.3.1 Global Medical Sevofluran Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Medical Sevofluran Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Medical Sevofluran Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Medical Sevofluran by Application
  1. 5.1 Medical Sevofluran Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adults
  4. 5.2 Global Medical Sevofluran Market Size by Application
  5. 5.2.1 Global Medical Sevofluran Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Medical Sevofluran Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Medical Sevofluran Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Medical Sevofluran Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Medical Sevofluran Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Medical Sevofluran Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Medical Sevofluran Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Medical Sevofluran Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott Laboratories
  2. 6.1.1 Abbott Laboratories Company Information
  3. 6.1.2 Abbott Laboratories Business Overview
  4. 6.1.3 Abbott Laboratories Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Laboratories Medical Sevofluran Product Portfolio
  6. 6.1.5 Abbott Laboratories Recent Developments
  7. 6.2 Hengrui
  8. 6.2.1 Hengrui Company Information
  9. 6.2.2 Hengrui Business Overview
  10. 6.2.3 Hengrui Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hengrui Medical Sevofluran Product Portfolio
  12. 6.2.5 Hengrui Recent Developments
  13. 6.3 Baxter
  14. 6.3.1 Baxter Company Information
  15. 6.3.2 Baxter Business Overview
  16. 6.3.3 Baxter Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Baxter Medical Sevofluran Product Portfolio
  18. 6.3.5 Baxter Recent Developments
  19. 6.4 Abbvie
  20. 6.4.1 Abbvie Company Information
  21. 6.4.2 Abbvie Business Overview
  22. 6.4.3 Abbvie Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Abbvie Medical Sevofluran Product Portfolio
  24. 6.4.5 Abbvie Recent Developments
  25. 6.5 Shenzhen Mindray Bio-Medical Electronics
  26. 6.5.1 Shenzhen Mindray Bio-Medical Electronics Company Information
  27. 6.5.2 Shenzhen Mindray Bio-Medical Electronics Business Overview
  28. 6.5.3 Shenzhen Mindray Bio-Medical Electronics Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Shenzhen Mindray Bio-Medical Electronics Medical Sevofluran Product Portfolio
  30. 6.5.5 Shenzhen Mindray Bio-Medical Electronics Recent Developments
  31. 6.6 Scott Medical Products
  32. 6.6.1 Scott Medical Products Company Information
  33. 6.6.2 Scott Medical Products Business Overview
  34. 6.6.3 Scott Medical Products Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Scott Medical Products Medical Sevofluran Product Portfolio
  36. 6.6.5 Scott Medical Products Recent Developments
  37. 6.7 Piramal
  38. 6.7.1 Piramal Company Information
  39. 6.7.2 Piramal Business Overview
  40. 6.7.3 Piramal Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Piramal Medical Sevofluran Product Portfolio
  42. 6.7.5 Piramal Recent Developments
  43. 6.8 Mylan Seiyaku
  44. 6.8.1 Mylan Seiyaku Company Information
  45. 6.8.2 Mylan Seiyaku Business Overview
  46. 6.8.3 Mylan Seiyaku Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Seiyaku Medical Sevofluran Product Portfolio
  48. 6.8.5 Mylan Seiyaku Recent Developments
  49. 6.9 Maruishi Pharmaceutical
  50. 6.9.1 Maruishi Pharmaceutical Company Information
  51. 6.9.2 Maruishi Pharmaceutical Business Overview
  52. 6.9.3 Maruishi Pharmaceutical Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Maruishi Pharmaceutical Medical Sevofluran Product Portfolio
  54. 6.9.5 Maruishi Pharmaceutical Recent Developments
  55. 6.10 Lunan
  56. 6.10.1 Lunan Company Information
  57. 6.10.2 Lunan Business Overview
  58. 6.10.3 Lunan Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Lunan Medical Sevofluran Product Portfolio
  60. 6.10.5 Lunan Recent Developments
  61. 6.11 Jinan MingRui
  62. 6.11.1 Jinan MingRui Company Information
  63. 6.11.2 Jinan MingRui Business Overview
  64. 6.11.3 Jinan MingRui Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jinan MingRui Medical Sevofluran Product Portfolio
  66. 6.11.5 Jinan MingRui Recent Developments
  67. 6.12 Hikma
  68. 6.12.1 Hikma Company Information
  69. 6.12.2 Hikma Business Overview
  70. 6.12.3 Hikma Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hikma Medical Sevofluran Product Portfolio
  72. 6.12.5 Hikma Recent Developments
  73. 6.13 Collins Ltd
  74. 6.13.1 Collins Ltd Company Information
  75. 6.13.2 Collins Ltd Business Overview
  76. 6.13.3 Collins Ltd Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Collins Ltd Medical Sevofluran Product Portfolio
  78. 6.13.5 Collins Ltd Recent Developments
  79. 6.14 BOC Healthcare
  80. 6.14.1 BOC Healthcare Company Information
  81. 6.14.2 BOC Healthcare Business Overview
  82. 6.14.3 BOC Healthcare Medical Sevofluran Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 BOC Healthcare Medical Sevofluran Product Portfolio
  84. 6.14.5 BOC Healthcare Recent Developments
7 North America by Country
  1. 7.1 North America Medical Sevofluran Sales by Country
  2. 7.1.1 North America Medical Sevofluran Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Medical Sevofluran Sales by Country (2021-2026)
  4. 7.1.3 North America Medical Sevofluran Sales Forecast by Country (2027-2032)
  5. 7.2 North America Medical Sevofluran Market Size by Country
  6. 7.2.1 North America Medical Sevofluran Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Medical Sevofluran Market Size by Country (2021-2026)
  8. 7.2.3 North America Medical Sevofluran Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Medical Sevofluran Sales by Country
  2. 8.1.1 Europe Medical Sevofluran Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Medical Sevofluran Sales by Country (2021-2026)
  4. 8.1.3 Europe Medical Sevofluran Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Medical Sevofluran Market Size by Country
  6. 8.2.1 Europe Medical Sevofluran Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Medical Sevofluran Market Size by Country (2021-2026)
  8. 8.2.3 Europe Medical Sevofluran Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Medical Sevofluran Sales by Country
  2. 9.1.1 Asia-Pacific Medical Sevofluran Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Medical Sevofluran Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Medical Sevofluran Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Medical Sevofluran Market Size by Country
  6. 9.2.1 Asia-Pacific Medical Sevofluran Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Medical Sevofluran Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Medical Sevofluran Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Medical Sevofluran Sales by Country
  2. 10.1.1 South America Medical Sevofluran Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Medical Sevofluran Sales by Country (2021-2026)
  4. 10.1.3 South America Medical Sevofluran Sales Forecast by Country (2027-2032)
  5. 10.2 South America Medical Sevofluran Market Size by Country
  6. 10.2.1 South America Medical Sevofluran Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Medical Sevofluran Market Size by Country (2021-2026)
  8. 10.2.3 South America Medical Sevofluran Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Medical Sevofluran Sales by Country
  2. 11.1.1 Middle East and Africa Medical Sevofluran Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Medical Sevofluran Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Medical Sevofluran Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Medical Sevofluran Market Size by Country
  6. 11.2.1 Middle East and Africa Medical Sevofluran Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Medical Sevofluran Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Medical Sevofluran Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Medical Sevofluran Value Chain Analysis
  2. 12.1.1 Medical Sevofluran Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Medical Sevofluran Production Mode & Process
  7. 12.2 Medical Sevofluran Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Medical Sevofluran Distributors
  10. 12.2.3 Medical Sevofluran Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst